- Tuesday, June
1st – 3:30 p.m.
ET -
MISSISSAUGA, ON, May 27, 2021 /PRNewswire/ - Nuvo
Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a
Miravo Healthcare (Miravo or the Company), a Canadian focused
healthcare company with global reach and a diversified portfolio of
commercial products, has been invited to present at the Summer
Solstice – Best Ideas from the Buy-Side conference, which is being
held virtually on June 1st
– 4th, 2021. Jesse
Ledger, Miravo's President & Chief Executive Officer and
Mary-Jane Burkett, Miravo's Vice
President & Chief Financial Officer will be presenting at the
conference.
|
DATE:
|
Tuesday, June
1st,, 2021
|
|
TIME:
|
3:30 p.m.
ET
|
|
LIVE PRESENTATION
/
REPLAY LINK:
|
https://www.webcaster4.com/Webcast/Page/2134/41516
|
Management will be available for one-on-one meetings to be held
throughout the conference. Investors can register here.
About the MicroCap Rodeo Summer Solstice Best Ideas
Conference
The MicroCap Rodeo is back with its third "Best
Ideas Bowl." This conference is a virtual conference that brings
you the top 35 best ideas from the buy side. Qualified
institutional investors recommended each of the 35 companies
represented as one of their best ideas. Those of you who attended
the 2019 MicroCap Rodeo in Austin,
Texas, know that we're focused on alpha. To receive
additional information, request an invitation or to schedule a
one-on-one meeting, please email
to:angie.goertz@issuerdirect.com.
About Miravo Healthcare
Miravo is a Canadian focused,
healthcare company with global reach and a diversified portfolio of
commercial products. The Company's products target several
therapeutic areas, including pain, allergy, neurology and
dermatology. The Company's strategy is to in-license and
acquire growth-oriented, complementary products for Canadian and
international markets. Miravo's head office is located in
Mississauga, Ontario, Canada, the
international operations are located in Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The
Varennes facility operates in a
Good Manufacturing Practices (GMP) environment respecting the U.S,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.miravohealthcare.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-present-at-summer-solstice---best-ideas-from-the-buy-side-301300732.html
SOURCE Nuvo Pharmaceuticals Inc.